Nalrexone Facilitated Discontinuation of Buprenorphine

NCT01895036 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Stable Opioid Dependence

Interventions

DRUG: Naltrexone

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]